Visana Health

Visana Health operates a virtual women's health clinic that treats a broad range of conditions across the female lifespan, including menopause and perimenopause, endometriosis, fibroids, PCOS (which the company refers to as PMOS, polyendocrine metabolic ovarian syndrome), thyroid disorders, painful or heavy periods, urinary tract and vaginal infections, sexual health concerns, postpartum care, breast concerns and osteoporosis prevention. It also provides preventive services such as well-woman visits, fertility assessments, mental health assessments, preventive screenings and lifestyle coaching, and has introduced a redesigned annual well-woman visit.

Care is delivered through an online patient portal, with virtual consultations of up to 45 minutes, a tailored care plan combining medication, supplements and lifestyle support, and care coordinators who arrange in-person labs, imaging, referrals, prescriptions and insurance navigation. The company states that roughly 90% of patients can have symptoms resolved without a pelvic exam and coordinates in-person exams when clinically indicated. Its in-house clinical team, led by Chief Medical Officer Dr. Barbara Levy, includes specialists in obstetrics, gynecology, midwifery, primary care, internal medicine, cardiology, psychology, psychiatry and dermatology, along with nurse practitioners and certified nurse midwives.

The company positions itself as a comprehensive, value-based virtual women's health clinic covering conditions "from menstruation to menopause" in a single care plan, and markets an actuarially driven reduction in total cost of care to payers.

Business model

Visana contracts with health plans and employers to provide virtual women's health services to their members and employees, and its services are covered by major insurance across all 50 states; Medicare and Medicaid plans are not accepted. The offering is positioned as value-based, with a lower actuarially driven cost of care replacing multiple narrower point solutions.

Revenue is derived from enterprise contracts with health plans and employers covering their populations, with the company marketing medical savings per patient and reduced cost of care as the payer value proposition; care is also billed through major insurance coverage.

Traction

Visana works with more than 40 employers covering over 1 million lives, and its health plan partners represent more than 35 million covered lives. The company reports a 78% reduction in unnecessary surgeries, 93% improvement in symptoms, a Net Promoter Score of 91, and $3,429 in medical savings per patient; an actuarial analysis cited a 34% reduction in employer medical costs and $2,400 in annual savings per enrollee.

Latest developments

In October 2025 the company announced a $24 million Series A round led by Noro-Moseley Partners, with participation from The Cigna Group Ventures, Intermountain Ventures, Flare Capital Partners and Frist Cressey Ventures, bringing total funding to $36 million. The financing is intended to fund expansion into weight loss, cardiometabolic care and chronic condition management including diabetes, thyroid disorders and cardiovascular disease, and to expand AI capabilities. The company has also announced a redesigned annual well-woman visit, appointed a Chief Clinical Officer to lead expansion of clinical scope and reach, and reported $3,429 in per-member savings for health plan and employer partners.